Skip to content

Clinical application of hotobiomodulation in preventing scar development after thyroidectomy

Clinical application of photobiomodulation in preventing scar development after thyroidectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083368
Enrollment
Unknown
Registered
2024-04-23
Start date
2024-04-25
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scar

Interventions

Experimental group:Photobiomodulation. The light source was 830nm LED, the energy density was 100 mW/cm2, the distance between the light source and the skin lesions was 17-20cm, and the irradiation ti
Control group:none

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients after thyroidectomy, and the surgical incision was the anterior neck. 2. No serious adverse reactions occurred within 2 weeks after surgery. 3. The patient has no systemic diseases such as photosensitive diseases. 4. People with normal behavioral ability and no history of mental illness.

Exclusion criteria

Exclusion criteria: 1. The patient has received relevant treatment or measures to prevent scar growth before, during or after surgery, including but not limited to pulsed dye laser, botox, silicone gel or silicone patch for external application. 2. Pregnant or lactating women. 3. People who have recently used photosensitive drugs. 4. Patients have difficulty in tolerating light modulation therapy.

Design outcomes

Primary

MeasureTime frame
Scar bulge number;

Secondary

MeasureTime frame
Vancouver Scar Scale;

Countries

China

Contacts

Public ContactWen Xiang

West China Hospital of Sichuan University

Xiangwen_wcums@163.com+86 153 5120 0113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026